Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1395 | Ribociclib | 0.01 | 0.6949 | 0.00260 |
| HCC1395 | Ribociclib | 0.01 | 0.6608 | 0.00970 |
| HCC1395 | Ribociclib | 0.01 | 0.7811 | 0.02432 |
| HCC1395 | Ribociclib | 0.0316227766017 | 0.8289 | 0.01253 |
| HCC1395 | Ribociclib | 0.0316227766017 | 1.0052 | 0.00382 |
| HCC1395 | Ribociclib | 0.0316227766017 | 0.6697 | 0.02118 |
| HCC1395 | Ribociclib | 0.1 | 0.6387 | 0.00715 |
| HCC1395 | Ribociclib | 0.1 | 0.7201 | 0.01326 |
| HCC1395 | Ribociclib | 0.1 | 0.4791 | 0.03841 |
| HCC1395 | Ribociclib | 0.316227766017 | 0.6727 | 0.01807 |
| HCC1395 | Ribociclib | 0.316227766017 | 0.6830 | 0.03823 |
| HCC1395 | Ribociclib | 0.316227766017 | 0.6934 | 0.03197 |
| HCC1395 | Ribociclib | 1.0 | 0.5462 | 0.06850 |
| HCC1395 | Ribociclib | 1.0 | 0.5082 | 0.01871 |
| HCC1395 | Ribociclib | 1.0 | 0.5902 | 0.07337 |
| HCC1395 | Ribociclib | 3.16227766017 | 0.6093 | 0.01424 |
| HCC1395 | Ribociclib | 3.16227766017 | 0.5272 | 0.01823 |
| HCC1395 | Ribociclib | 3.16227766017 | 0.5009 | 0.02558 |
| HCC1395 | Ribociclib | 10.0 | 0.4342 | 0.05359 |
| HCC1395 | Ribociclib | 10.0 | 0.4226 | 0.03402 |
| HCC1395 | Ribociclib | 10.0 | 0.3894 | 0.05463 |
| HCC1395 | LY3023414 | 0.001 | 0.6313 | 0.02690 |
| HCC1395 | LY3023414 | 0.001 | 0.5287 | 0.02133 |
| HCC1395 | LY3023414 | 0.001 | 0.3966 | 0.03653 |
| HCC1395 | LY3023414 | 0.00316227766017 | 0.3520 | 0.03373 |